Journal of NeuroscienceNeurosciencePeer-reviewed journal article
Attenuated single neuron and network hyperexcitability following microRNA-134 inhibition in mice with drug-resistant temporal lobe epilepsy
Pablo Quintana-SartiiD, Jordan HigginsiD, Cristina Ruedell ReschkeiD, Mona HeilandiD, Amaya Sanz‐Rodriguez, Stephen F. MaddeniD, Mark O. CunninghamiD, Omar MamadiD, David Clifford HenshalliD
Abstract
The multi-factorial pathophysiology of acquired epilepsies lends itself to a multi-targeting therapeutic approach. MicroRNAs (miRNA) are short noncoding RNAs that individually can negatively regulate dozens of protein-coding transcripts. Previously, we reported that central injection of antisense oligonucleotides targeting microRNA-134 (Ant-134) shortly after status epilepticus potently suppressed the development of recurrent spontaneous seizures in rodent models of temporal lobe epilepsy. The mechanism(s) of these anti-seizure effects remain, however, incompletely understood. Here we show that intracerebroventricular microinjection of Ant-134 in male mice with pre-existing epilepsy caused by intraamygdala kainic acid-induced status epilepticus potently reduces the occurrence of spontaneous seizures. Recordings from ex vivo brain slices collected 2-4 days after Ant-134 injection in epileptic mice, detected a number of electrophysiological phenotypic changes consistent with reduced excitability. Specifically, Ant-134 reduced action potential bursts after current injection in CA1 neurons and reduced miniature excitatory post-synaptic current frequencies in CA1 neurons. Ant-134 also reduced general network excitability, including attenuating pro-excitatory CA1 responses to Schaffer collateral stimulation in hippocampal slices from epileptic mice. Together, the present study demonstrates inhibiting miR-134 reduces single neuron and network hyperexcitability in mice and extends support for this approach to treat drug-resistant epilepsies. Significance statementTemporal lobe epilepsy is one of the most common forms of drug-resistant epilepsy. Identifying molecular regulators of enduring states of hyperexcitability may lead to new therapeutic approaches. MicroRNAs are short noncoding RNAs that act post-transcriptionally to lower levels of sets of protein-coding genes. Here we show that inhibiting miR-134 reduces spontaneous seizures in mice with active epilepsy. Electrophysiologic recordings from brain slices collected when mice were transitioning to fewer seizures revealed changes to both single neuron and inter-regional communication properties that may explain the reduction in hippocampal network excitability. The findings support the development of this microRNA-targeting approach for epilepsy.
- organism: mouse
- assay: electronic health records
- research focus: cell type annotation
- research focus: differential expression
- research focus: spatial domain detection
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 8th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MicroRNA inhibition using antimiRs in acute human brain tissue sections
Gareth Morris, Elena Langa, … David Clifford Henshall·EpilepsiaPeer-reviewed·Jun 3, 2022
- Potent and lasting seizure suppression by systemic delivery of antagomirs targeting miR-134 timed with blood-brain barrier disruption
Cristina Ruedell Reschke, Luiz Fernando Almeida Silva, … David Clifford Henshall·bioRxiv·Oct 8, 2019
- MicroRNA-335-5p suppresses voltage-gated sodium channel expression and may be a target for seizure control
Mona Heiland, Niamh M. C. Connolly, … David Clifford Henshall·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 18, 2023
- A systems approach delivers a functional microRNA catalog and expanded targets for seizure suppression in temporal lobe epilepsy
Morten Trillingsgaard Venø, Cristina Ruedell Reschke, … David Clifford Henshall·bioRxiv·Sep 24, 2019
- Chemogenetic activation of parvalbumin interneurons in the piriform cortex alleviates hippocampal focal seizures
Huiqi Zhang, Zhuo Huang, C. Geoffrey Lau·bioRxiv·Dec 22, 2023
- High concordance between hippocampal transcriptome of the intraamygdala kainic acid model and human temporal lobe epilepsy
Giorgia Conte, Alberto Parras, … Tobías Engel·EpilepsiaPeer-reviewed·Oct 18, 2020